Neurological Diseases
-
Novel compounds open new research avenues for Alzheimer’s disease therapeutics
Two new compounds developed at the Vanderbilt University Warren Center for Neuroscience Drug Discovery will enable research into a protein family with ties to Alzheimer’s disease, setting the stage for the development of a different kind of therapeutic than is currently available. Read MoreFeb. 24, 2026
-
Brain Disorders Research
Link List – Right Hand Column PlaceholderRefresh After Saving to Remove .link-list.jump-links{ padding-left: 0 !important; } CENTERS & INSTITUTES: Vanderbilt Center for Addiction Research (VCAR) Warren Center for Neuroscience Drug Discovery (WCNDD) Vanderbilt Brain Institute The Brain Diseases affecting the… Read MoreJan. 9, 2026